Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-16-005826
Filing Date
2016-05-10
Accepted
2016-05-10 16:55:05
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 bpmc-20160510xs3.htm S-3 694297
2 EX-4.2 bpmc-20160510ex42cb7201a.htm EX-4.2 879240
3 EX-4.3 bpmc-20160510ex43f0ba6fd.htm EX-4.3 994623
4 EX-5.1 bpmc-20160510ex51671d0aa.htm EX-5.1 32193
5 EX-12.1 bpmc-20160510ex121fb6260.htm EX-12.1 53214
6 EX-23.1 bpmc-20160510ex231ff90f2.htm EX-23.1 4533
  Complete submission text file 0001558370-16-005826.txt   2659054
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-211266 | Film No.: 161636534
SIC: 2834 Pharmaceutical Preparations